Latest round

Series A

Last raised

Jan 2024

Total raised

Undisclosed

Investors

1

About Fuhan

Established in 2018 and based in Nanjing, China, Fuhan operates as a technology-focused enterprise dedicated to the research and development of products and services in the field of children's Ophthalmic healthcare. It acquired more than 50 national patents, including more than 20 utility model and invention patents, and more than 10 software copyrights. Fuhan also acquired High-tech Enterprise and Innovative Enterprise titles. The company mainly provides ophthalmic wide-area imaging system, which include Kiretem-01, Kiretem Ultra, and Kiretem Mini. Kiretem Ophthalmic Wide-Angle lmaging System is equipment for screening fundus disease of infants and children in clinical practice, which is conducive to early detection of a variety of neonatal congenital eye diseases and fundus lesions. Fuhan also provides intelligent AI-assisted judgment system and baby examination bed. The company's products serve the diagnosis and treatment of eye diseases in newborns, children and surgical patients. The company will register and launch the first domestic OCT equipment suitable for posterior segment imaging of infants and young children in 2024, and complete the development and promotion of C-end physiological parameter monitors, hospital-end iris dilators and other products in 2025.

Who invested in Fuhan

1 investor across 1 round

See all investors in Fuhan

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 12, 2024

    Amount

    Undisclosed

    Investors

    Locked

Questions about Fuhan

Who invested in Fuhan?

Fuhan has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Fuhan raised?

Fuhan has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Fuhan last raise money?

Fuhan's most recent round on record is a Series A, in Jan 2024.

What does Fuhan do?

Established in 2018 and based in Nanjing, China, Fuhan operates as a technology-focused enterprise dedicated to the research and development of products and services in the field of children's Ophthalmic healthcare.

Where is Fuhan headquartered?

Fuhan is headquartered in Nanjing, China.

Which VCs invest in companies like Fuhan?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at Fuhan's stage. Their profiles are linked below.

Raising like Fuhan? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.